= Emerging. More than 5 years before clinical availability. (9.82%)
= Expected to be clinically available in 1 to 4 years. (12.95%)
= Clinically available now. (22.77%)
MSACL 2018 EU : Drouin

MSACL 2018 EU Abstract

Topic: Metabolomics

Podium Presentation in the Ether on Wednesday at 11:00 (Chair: Elizabeth Want)

New Insights in CE-MS-based Metabolomics

Nicolas Drouin (Presenter)
University of Geneva

Presenter Bio(s): I recently defenced my PhD. During my thesis work I focused on sample preparation and separation of highly polar compounds using electroassisted method such as electromembrane extraction and capillary electrophoresis respectively. In this context, I developped a new approach for features identification in untargeted metabolomic with CE-MS. This innovative approach is based on the conversion of migration time scale into an effective mobility (µeff) scale of the data and an experimental µeff based library of more than 400 endogenous compounds.

Authors: Nicolas Drouin, Julian Pezzati, Yoric Gagnebin, Victor Gonzalez-Ruiz, Julie Schappler, Serge Rudaz
School of Pharmaceutical Sciences, Unviersity of Geneva, Geneva, Switzerland

Abstract

During this study, we developed an original workflow for features identification in CE-MS. This innovative approach is based on the conversion of migration time scale into an effective mobility (µeff) scale of data acquired in standardized conditions and an experimental µeff based library of more than 400 endogenous compounds.

This method allowed lab-to-lab identification of features from cell cultures.


Financial Disclosure

DescriptionY/NSource
Grantsno
SalaryyesUniversity of Geneva
Board Memberno
Stockno
Expensesno
IP Royaltyno

Planning to mention or discuss specific products or technology of the company(ies) listed above:

no